US$ 22.98
soul trial oral semaglutide cardiovascular outcomes 2024 results Semaglutide's Impact on Events in Type 2 Diabetes Patients with Cardiovascular and Kidney Disease: SOUL: Oral Semaglutide Cuts CV
Description
122 , 248.e5256.e5 (2009)

doi:10.1007/s11920-017-0834-2 Ee C, Pirotta S, Mousa A, Moran L, Lim S

Nagao M, Hayashi H

Standard shipping is $18.00 unless the free-shipping threshold is reached
